Causes and Natural History of Dyslipidemias
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Study ID
- NCT00353782
- Status
- Recruiting
Conditions
- Atherosclerosis
- Hypercholesterolemia
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 100 Years
- Healthy Volunteers
- Not accepted
Study Details
This study will evaluate people with dyslipidemias - disorders that affect the fat content in the blood. Fats, or lipids, such as cholesterol and triglycerides, are carried in the blood in particles called lipoproteins. These particles are involved in causing blood vessel diseases that can lead to conditions like atherosclerosis (hardening of the arteries) or heart attack. Participants will undergo accepted medical tests and procedures to evaluate their condition. Most of the test results are helpful in making a diagnosis and in guiding treatment. People with lipid disorders are eligible for this study. Representative types of patients include those with: * Plasma cholesterol levels greater than 200 mg/dl or less than 120 mg/dl * Plasma LDL-C levels greater than 130 mg/dl or less than 70 mg/dl * Plasma HDL-C levels greater than 70 mg/dl or less than 25 mg/dl * Unusual cholesterol deposits or xanthomas (nodules of lipid deposits on the skin) Children under 2 years of age are excluded from the study. Participants will undergo some or all of the following procedures: \- Plasma evaluation. Apolipoproteins (plasma proteins involved in metabolism of cholesterol, triglycerides, phospholipids, and proteins in the blood) and enzymes involved in lipid metabolism are measured.
Key Dates
- Start date
- Oct 14, 2003
- Status verified
- Jun 2026
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: DyslipidemiaDyslipidemia
Primary Outcome Measure
permit a full evaluation of the lipoproteins, apolipoproteins, and cellular enzymes and receptors relevant to lipoprotein metabolism in order to accurately diagnose and treat patients with potential genetic defects in these processes [ Time Frame: 25 years ]
Central Contacts
- Robert D Shamburek, M.D.(301) 496-3460
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | - |
Find similar trials in Bethesda, MD
Related Studies
- Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular SystemRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Washington D.C., District of Columbia
- New Heart Imaging Techniques to Evaluate Possible Heart DiseaseRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPHASE4 · Recruiting · VA Office of Research and Development · Phoenix, Arizona
- PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]Recruiting · Johns Hopkins University · Baltimore, Maryland